Please enter verification code
Confirm
Anesthetic Considerations on Pulmonary Hypertension: A Case Report and Minireview
Clinical Medicine Research
Volume 3, Issue 6, November 2014, Pages: 200-202
Received: Dec. 7, 2014; Accepted: Dec. 12, 2014; Published: Dec. 19, 2014
Views 3447      Downloads 201
Authors
Andi Koraqi, Department of Microbiology, “Mother Teresa” University Hospital Centre, Albania
Denada Lacej, Department of Microbiology, “Mother Teresa” University Hospital Centre, Albania
Rezart Xhani, Department of Surgery, Division of Urology, “Mother Teresa” University Hospital Centre, Albania
Myzafer Kaci, Department of Surgery, Division of General Surgery, “Mother Teresa” University Hospital Centre, Albania
Gjergj Andrea, Department of Surgery, Division of General Surgery, “Mother Teresa” University Hospital Centre, Albania
Rudin Domi, Department of Surgery, Division of Anaesthesiology and Intensive Care, “Mother Teresa” University Hospital Centre, Albania
Article Tools
Follow on us
Abstract
Pulmonary hypertension presents a great challenge to the anesthesiologist. The number of patients suffering from pulmonary hypertension presenting for surgery is increasing because of increased age and the modern medical and surgical therapy as well. We present a case of a patient suffering from pulmonary hypertension scheduled for left radical nephrectomy due to left kidney tumor. Preoperative optimization and prevention of deterioration of pulmonary hypertension and right side heart failure are the problems the anesthesiologist must deal with. A good collaboration among cardiologist, anesthesiologist, and the surgeon can guarantee the patient’s outcome.
Keywords
General Anesthesia, Pulmonary Hypertension, Right Heart Failure
To cite this article
Andi Koraqi, Denada Lacej, Rezart Xhani, Myzafer Kaci, Gjergj Andrea, Rudin Domi, Anesthetic Considerations on Pulmonary Hypertension: A Case Report and Minireview, Clinical Medicine Research. Vol. 3, No. 6, 2014, pp. 200-202. doi: 10.11648/j.cmr.20140306.17
References
[1]
Loyd J, Butler M, Foround T, et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 152:93-97.
[2]
Fox Ch, Kalarickal Ph, Yarboruough M, Jin J. Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for non cardiac surgery. Curr Opin Anaesthesiol 2008; 21:467-472.
[3]
Gaine S. Pulmonary hypertension. JAMA 2000; 284: 3160-3168.
[4]
Blaise G, Langleben D, Hubert B. Pulmonary artery hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003; 99:1415-1432.
[5]
Bossone E, Paciaccio G, Larussi D et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest 2002; 121:513-518.
[6]
Nauser T, Stives S. Diagnosis and treatment of pulmonary hypertension. Ann Fam Phys 2001; 63: 1789-1796.
[7]
Tanake H, Tajimi K, Moritsune O, et al. Effects of lirinone on pulmonary vasculature in normal dogs and dogs with pulmonary hypertension. Crit Care Med 1991; 19:68-74.
[8]
Ichinose F, Roberts J, Zapol W. Inhaled nitric oxide: a selective pulmonary vasodilator-current uses and therapeutic potential. Circulation 2004; 109: 3106-3111.
[9]
Cabrol S, Sousa S, Jaix X, et al. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2007; 26:357-362.
[10]
Wilkens H, Guth A, Konig J, et al. Effect of iloprost plus oral sildenafil in patient with primary pulmonary hypertension. Circulation 2001; 104:1218-1222.
[11]
Gordon C, Colard Ch, Pan W. Intraoperative management of pulmonary hypertension and associated right heart failure. Curr Opin Anaesthesiol 2010; 23: 49-56.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186